Stock Fundamentals

Company Information

Company Name
Xeris Pharmaceuticals Inc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: US98422E1038
CIK: 0001346302
CUSIP: 98422L107
Currency: USD
Full Time Employees: 435
Phone: 844 445 5704
Fiscal Year End: December
IPO Date: Jun 21, 2018
Description:

Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

Address:

1375 West Fulton Street, Chicago, IL, United States, 60607

Directors & Officers

Name Title Year Born
Mr. John P. Shannon CEO & Director 1962
Mr. Kevin McCulloch President & COO 1964
Mr. Steven M. Pieper Chief Financial Officer 1977
Ms. Beth P. Hecht J.D. Chief Legal Officer & Corporate Secretary 1964
Dr. Anh T. Nguyen M.B.A., M.D. Chief Medical Officer 1975
Ms. Allison Wey Senior Vice President of Investor Relations & Corporate Communications NA
Mr. Brian Conner SVP of Quality and Chief Compliance & Risk Officer NA
Ms. Kendal Korte Senior Vice President of Human Resources NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 01, 2026 Beth Hecht N/A Sale 16.67K $5.99 $99.84K
Mar 30, 2026 James Aloysius Brady N/A Sale 10.83K $5.54 $60.02K
Mar 02, 2026 Beth Hecht N/A Sale 16.67K $6.25 $104.17K
Feb 02, 2026 Beth Hecht N/A Sale 16.67K $7.45 $124.17K
Jan 08, 2026 Kevin Mcculloch N/A Sale 15.00K $8.00 $120.00K
Jan 05, 2026 John Patrick Shannon Jr N/A Sale 24.91K $7.08 $176.34K
Jan 02, 2026 Beth Hecht N/A Sale 16.67K $7.43 $123.84K
Dec 19, 2025 John Johnson N/A Sale 135.40K $7.22 $977.59K
Dec 12, 2025 Barbara-Jean A Bormann-Kennedy N/A Sale 15.00K $7.09 $106.35K
Dec 01, 2025 Beth Hecht N/A Sale 16.67K $7.01 $116.84K
Nov 13, 2025 John Patrick Shannon Jr N/A Sale 23.24K $7.46 $173.39K
Nov 11, 2025 Beth Hecht N/A Sale 16.67K $7.40 $123.34K
Sep 11, 2025 Marla Persky N/A Sale 15.50K $7.72 $119.66K
Aug 28, 2025 Jeffrey W Sherman N/A Sale 42.23K $7.92 $334.48K
Aug 13, 2025 John Johnson N/A Sale 107.50K $7.32 $786.90K
Aug 12, 2025 Dawn Halkuff N/A Sale 42.50K $7.28 $309.40K
Jun 13, 2025 Kevin Mcculloch N/A Purchase 25.00K $4.38 $109.50K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 12.95M Mar 31, 2026 7.50% $0.00 2.42%
Vanguard Group Inc 11.19M Dec 31, 2025 6.48% $0.00 13.83%
D. E. Shaw & Co LP 7.79M Mar 31, 2026 4.51% $0.03 2.82%
Vanguard Capital Management, LLC 6.98M Mar 31, 2026 4.04% $0.00 0.00%
State Street Corp 4.66M Mar 31, 2026 2.70% $0.00 13.15%
Geode Capital Management, LLC 4.29M Mar 31, 2026 2.49% $0.00 0.34%
Qube Research & Technologies 4.11M Mar 31, 2026 2.38% $0.03 17.62%
Rosalind Advisors, Inc. 3.23M Mar 31, 2026 1.87% $7.53 53.04%
Nuveen, LLC 2.92M Mar 31, 2026 1.69% $0.00 3.91%
Vanguard Portfolio Management, LLC 2.67M Mar 31, 2026 1.54% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 2.57M Mar 31, 2026 1.49% $0.00 -4.99%
Millennium Management LLC 2.27M Mar 31, 2026 1.31% $0.01 163.78%
Wellington Management Company LLP 2.17M Mar 31, 2026 1.26% $0.00 -5.04%
Two Sigma Investments LLC 1.92M Mar 31, 2026 1.11% $0.01 11.05%
Armistice Capital, LLC 1.91M Mar 31, 2026 1.11% $0.20 0.00%
Legal & General Group PLC 1.91M Mar 31, 2026 1.11% $0.00 36.67%
Parkman Healthcare Partners LLC 1.72M Mar 31, 2026 1.00% $1.03 1.75%
UBS Group AG 1.65M Mar 31, 2026 0.95% $0.00 173.56%
The Goldman Sachs Group Inc 1.61M Mar 31, 2026 0.93% $0.00 2.88%
Northern Trust Corp 1.44M Mar 31, 2026 0.84% $0.00 4.17%

Shares Statistics

Shares Outstanding: 172.64M
Shares Float: 163.74M
% Insiders: 338.00%
% Institutions: 6,229.60%
Short % Float: 7.50%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 4.95M 2.87% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 3.79M 2.20% ▲ 0.93% May 29, 2026
3 Vanguard Institutional Extnd Mkt Idx Tr 1.86M 1.08% ▲ 0.50% Apr 30, 2026
4 CREF Total Global Stock Account R3 1.61M 0.93% ▲ 0.00% Apr 30, 2026
5 Fidelity Small Cap Index 1.56M 0.90% ▲ 3.73% Mar 31, 2026
6 iShares Russell 2000 Growth ETF 1.29M 0.75% ▼ 0.65% May 29, 2026
7 Nuveen Quant Small Cap Equity R6 1.22M 0.71% ▲ 0.00% Apr 30, 2026
8 State Street® SPDR® S&P® PhrmctlsETF 1.06M 0.61% ▲ 0.00% May 31, 2026
9 Russell 2000 Equity Index Fund B 958.08K 0.56% ▼ 0.05% Dec 31, 2025
10 State St Russell Sm/Mid Cp® Indx SL Cl I 938.43K 0.54% ▲ 0.00% May 31, 2026

Valuation Metrics

Enterprise Value: $1.32B
Trailing P/E: 97.00
Forward P/E: 84.75

Financial Highlights

Market Cap: $1.17B
EBITDA: $48.08M
P/E Ratio: $97.00
Book Value: $0.08
Earnings/Share: $0.07
Profit Margin: 3.81%
Operating Margin: 9.52%
ROA (TTM): 6.34%
ROE (TTM): -617.16%
Revenue (TTM): $314.85M
Revenue/Share (TTM): $1.91
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 38.30%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.19x 16.55x 0.96x 0.86x 17.83x
2024-12-31 1.67x -8.04x 1.09x -1.01x -17.02x
2023-12-31 1.64x -28.67x 1.02x -1.65x -8.19x
2022-12-31 2.54x 4.17x 0.87x -5.81x -2.72x
2021-12-31 1.80x 0.94x 0.69x -16.04x -0.79x
2020-12-31 3.20x 6.03x 0.87x -17.09x -0.74x
2019-12-31 3.20x 4.04x 0.87x -17.09x -0.49x
2018-12-31 11.59x 0.53x 0.37x -23.32x -0.70x
2017-12-31 9.06x -0.04x 2.29x -13,314.50x -0.10x
2016-12-31 13.13x -0.03x 1.95x -6,615.50x -0.07x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about XERS.US!